What Happened?
, -based Moderna Therapeutics Appointed Tim Faubert as Executive Director, Digital Finance and Procurement
Date of management change: May 25, 2022
, -based Moderna Therapeutics Appointed Tim Faubert as Executive Director, Digital Finance and Procurement
Moderna is a clinical stage pioneer of messenger RNA Therapeutics™, an entirely new in vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of diseases and conditions. Moderna is developing and plans to commercialize its innovative mRNA drugs through its own ventures and its strategic relationships with established pharmaceutical and biotech companies. Its current ventures are: Onkaido, focused on oncology, Valera, focused on infectious diseases, Elpidera, focused on rare diseases, and Caperna, focused on personalized cancer vaccines. Cambridge-based Moderna is privately held and currently has strategic agreements with AstraZeneca, Alexion Pharmaceuticals and Merck.
Tim Faubert is Executive Director, Digital Finance and Procurement at Moderna Therapeutics. Previously, Tim held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Rohloff Brian, Simmons Dan, Ginsberg Jennifer, Linnington Max, Neidhart Cassie, Raia Christopher, Pointer Sally, Livingston Carolyn, Hansen Mark, Marshall Donna, McColly Kevin
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.